Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy.

ABSTRACT:

Background

The impact of prostate radiotherapy on patient-reported health-related quality of life (HRQoL) significantly influences the outcomes of metastatic prostate cancer. We measured and compared HRQoL of metastatic prostate cancer patients who received cytoreductive prostate radiotherapy.

Methods

Between November 23, 2020, and November 21, 2022, we recruited 70 metastatic prostate cancer patients at the Department of Clinical Oncology at Suez Canal University Hospital. Patients were eligible if they had synchronous and metachronous histopathological confirmed metastatic adenocarcinoma and an Eastern Cooperative Oncology Group performance status ≤ 2. Random allocation was performed for either definitive local radiotherapy concurrent with the standard androgen deprivation

SUBMITTER: Ayoub HM 

PROVIDER: S-EPMC10544568 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature